Difference in magnitude of psychostimulant-induced extracellular norepinephrine in the ventral tegmental area contributes to discrepant prefrontal dopamine outflow

Addiction Biology

Volumn 12, Issue 1, 2007, Pages 51-58

  Pan, Wynn H T ^a   Hsieh, Min Chien ^a   Wu, Hsiao Hua ^a   Lin, Shi Kwang ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI CITY PSYCHIATRIC CENTER   (Taiwan)

Author keywords

Amphetamine; Cocaine; Dopamine; Norepinephrine; Prefrontal cortex; Ventral tegmental area

Indexed keywords

AMPHETAMINE; COCAINE; DOPAMINE; NORADRENALIN; PSYCHOSTIMULANT AGENT;

ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; VENTRAL TEGMENTUM;

AFFERENT PATHWAYS; AMPHETAMINE; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; DOPAMINE; EXTRACELLULAR FLUID; MALE; NOREPINEPHRINE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; VENTRAL TEGMENTAL AREA;

EID: 33947115466     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2006.00044.x     Document Type: Article

References (38)

1. Bayer VE, Pickel VM (1990) Ultrastructural localization of tyrosine hydroxylase in the rat ventral tegmental area: relationship between immunolabelling density and neuronal associations. J Neurosci 10:2996-3013.
2. Beart PM, McDonald D (1982) 5-hydroxytryptamine and 5- hydroxytryptaminergic-dopaminergic interactions in the ventral tegmental area of rat brain. J Pharm Pharmacol 34:591-593.
3. Cameron DL, Williams JT (1993) Dopamine D1 receptors facilitate transmitter release. Nature 366:344-347.
4. Chen NH, Pan WHT (2000) Regulatory effects of D2 receptors in the ventral tegmental area on the mesocorticolimbic dopaminergic pathway. J Neurochem 74:2576-2582.
5. 3H]serotonin release in vitro induced by electrical stimulation in A9 and A10 dopamine regions of rat brain: characterization and responsiveness to cocaine. J Pharmacol Exp Ther 267:379-389.
6. Chen NH, Reith MEA (1994) Effects of locally applied cocaine, lidocaine, and various uptake blockers on monoamine transmission in the ventral tegmental area of freely moving rats: a microdialysis study on monoamine interrelationship. J Neurochem 63:1701-1713.
7. Ciliax BJ, Heilman C, Demchyshyn LL, Pristupa ZB, Ince E, Hersch SM, Niznik HB, Levey AI (1995) The dopamine transporter: immunochemical characterization and localization in brain. J Neurosci 15:1714-1723.
8. Cragg SJ, Greenfield SA (1997) Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum. J Neurosci 17:5738-5746.
9. Fleckenstein AE, Gibb JW, Hanson GR (2000) Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity. Eur J Pharmacol 406:1-13.
10. Grenhoff J, Svensson TH (1993) Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area. Eur J Pharmacol 233:79-84.
11. Groves PM, Wilson CJ, Young SJ, Rebec GV (1975) Self-inhibition by dopaminergic neurons. Science 190:522-528.
12. Guan XM, McBride WJ (1989) Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release. Brain Res Bull 23:541-547.
13. 2+ dependence of the amphetamine, nomifensine, and Lu 19-005 effect on in vivo dopamine transmission. Eur J Pharmacol 166:261-269.
14. Johnson SW, Mercuri NB, North RA (1992) 5-hydroxytryptamine 1B receptors block the GABAB synaptic potential in rat dopamine neurons. J Neurosci 12:2000-2006.
15. Jones SR, Joesph JD, Barak LS, Caron MG, Wightman RM (1999) Dopamine neuronal transport kinetics and effects of amphetamine. J Neurochem 73:2406-2414.
16. Kalivas PW (1993) Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res Brain Res Rev 18:75-113.
17. Kalivas PW, Bourdelais A, Abhold R, Abbott L (1989) Somatodendritic release of endogenous dopamine: in vivo dialysis in the A10 dopamine region. Neurosci Lett 100:215-220.
18. Kalivas PW, Nakamura M (1999) Neural systems for behavioral activation and reward. Curr Opin Neurobiol 9:223-227.
19. Lategan AJ, Marien MR, Colpaert FC (1992) Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: a microdialysis study. Life Sci 50:995-999.
20. Linner L, Endersz H, Ohman D, Bengtsson F, Schalling M, Svensson TH (2001) Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex. J Pharmacol Exp Ther 297:540-546.
21. 3H-GBR 12935. J Neural Transm Gen Sect 87:1-14.
22. Nagahiro S, Diksic M, Yamamoto YL, Riml H (1990) Noninvasive in-vivo autoradiographic method to measure axonal transport in serotoninergic neurons in the rat brain. Brain Res 506:120-128.
23. Nirenberg MJ, Chan J, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM (1997) Immunogold localization of the dopamine transporter: an ultrastructural study of the rat ventral tegmental area. J Neurosci 17:5255-5262.
24. Pacholczyk T, Blakely RD, Amara SG (1991) Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 350:350-354.
25. Pan WHT, Chen NH, Tsai FY, Liao HY (1996a) Intrategmental infusion of cocaine decreases dopamine release and enhances norepinephrine release in the medial prefrontal cortex. Eur J Pharmacol 317:205-213.
26. Pan WHT, Sung JC, Fuh SMR (1996b) Locally application of amphetamine into the ventral tegmental area enhances dopamine release in the nucleus accumbens and the medial prefrontal cortex through noradrenergic neurotransmission. J Pharmacol Exp Ther 278:725-731.
27. Pan WHT, Yang SY, Lin SK (2004) Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex. Synapse 53:44-52.
28. Paxinos G, Watson C (1998) The Rat Brain in Stereotaxic Coordinates, 4th edn. London: Academic Press.
29. Pifl C, Agner E, Drobny H, Sitte HH, Singer EA (1999) Amphetamine reverses or blocks the operation of the human noradrenaline transporter depending on its concentration: superfusion studies on transfected cells. Neuropharmacology 38:157-165.
30. Reith MEA, Li MY, Yan QS (1997) Extracellular dopamine, norepinephrine, and serotonin in the ventral tegmental area and nucleus accumbens of freely moving rats during intracerebral dialysis following systemic administration of cocaine and other uptake blockers. Psychopharmacology 134:309-317.
31. Ritz MC, Cone EJ, Kuhar MJ (1990) Cocaine inhibition of ligand binding at dopamine, norepinephrine, and serotonin transporters: a structure-activity study. Life Sci 46:635-645.
32. Ritz MC, Kuhar MJ (1989) Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine. J Pharmacol Exp Ther 248:1010-1017.
33. Robinson TE, Berridge KC (2000) The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 95:S91-S117.
34. Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, Partilla JS (2001) Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39:32-41.
35. Shi WX, Pun CL, Smith PL, Bunney BS (2000) Endogenous DAmediated feedback inhibition of DA neurons: involvement of both D1- and D2-like receptors. Synapse 35:111-119.
36. Shi WX, Pun CL, Zhou Y (2004) Psychostimulants induce lowfrequency oscillations in the firing activity of dopamine neurons. Neuropsychopharmacology 29:2160-2167.
37. Tanda G, Pontieri FE, Frau R, Di Chiara G (1997) Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur J Neurosci 9:2077-2085.
38. White FJ, Wang RY (1984) Pharmacological characterization of DA autoreceptors in the VTA. J Pharmacol Exp Ther 231:275-280.